Lidewij Sophia Boogers
Overview
Explore the profile of Lidewij Sophia Boogers including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
21
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
van der Loos M, Boogers L, Klink D, den Heijer M, Wiepjes C, Hannema S
Eur J Endocrinol
. 2024 Oct;
191(4):426-432.
PMID: 39353071
Objective: Bone mineral density (BMD) Z-scores decrease during puberty suppression in transgender youth. Assessment of treatment impact has been based on the assumption that without intervention, BMD Z-scores remain stable....
2.
Boogers L, Sikma B, Bouman M, van Trotsenburg A, den Heijer M, Wiepjes C, et al.
J Clin Endocrinol Metab
. 2024 Aug;
PMID: 39150993
Context: Skeletal dimensions vary between sexes. Men typically have broader shoulders and women a wider pelvis. If gender affirming hormone therapy (GAHT) with or without prior puberty suppression (PS) alters...
3.
Boogers L, Reijtenbagh S, Wiepjes C, van Trotsenburg A, den Heijer M, Hannema S
J Clin Endocrinol Metab
. 2023 Dec;
109(8):e1593-e1601.
PMID: 38128064
Context: Transgender adolescents can undergo puberty suppression (PS) and subsequent gender-affirming hormone therapy (GAHT) but little information is available on the expected rate of physical changes. Objective: To investigate the...
4.
Boogers L, van der Loos M, Wiepjes C, van Trotsenburg A, den Heijer M, Hannema S
Eur J Endocrinol
. 2023 Aug;
189(2):290-296.
PMID: 37590955
Objective: Treatment in transgender girls can consist of puberty suppression (PS) with a gonadotropin-releasing hormone agonist (GnRHa) followed by gender-affirming hormonal treatment (GAHT) with estrogen. Bone mineral density (BMD) Z-scores...
5.
Willemsen L, Boogers L, Wiepjes C, Klink D, van Trotsenburg A, den Heijer M, et al.
J Clin Endocrinol Metab
. 2022 Oct;
108(2):414-421.
PMID: 36190924
Context: Growth is an important topic for many transgender boys. However, few studies have investigated the impact of puberty suppression (PS) and gender-affirming hormone treatment (GAHT) on growth and adult...
6.
Boogers L, Wiepjes C, Klink D, Hellinga I, van Trotsenburg A, den Heijer M, et al.
J Clin Endocrinol Metab
. 2022 Jun;
107(9):e3805-e3815.
PMID: 35666195
Context: Transgender adolescents can receive gonadotropin-releasing hormone analogues (GnRH) and gender-affirming hormone therapy (GAHT), but little is known about effects on growth and adult height. This is of interest since...